celecoxib has been researched along with Cardiac Remodeling, Ventricular in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore the effects of celecoxib on pressure overload-induced cardiac hypertrophy (CH), cardiac dysfunction and explore the possible protective mechanisms." | 7.83 | Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress. ( Hao, F; Kang, Y; Liu, Y; Si, M; Su, L; Wang, F; Wang, H; Xin, X; Xu, J; Xue, F; Xue, M; Yu, L; Zhang, C; Zhang, Y, 2016) |
| "To explore the effects of celecoxib on pressure overload-induced cardiac hypertrophy (CH), cardiac dysfunction and explore the possible protective mechanisms." | 3.83 | Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress. ( Hao, F; Kang, Y; Liu, Y; Si, M; Su, L; Wang, F; Wang, H; Xin, X; Xu, J; Xue, F; Xue, M; Yu, L; Zhang, C; Zhang, Y, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q | 1 |
| Zhu, L | 1 |
| Yip, KM | 1 |
| Tang, Y | 1 |
| Liu, Y | 2 |
| Jiang, T | 1 |
| Zhang, J | 1 |
| Zhao, Z | 1 |
| Yi, T | 1 |
| Chen, H | 1 |
| Zhang, C | 1 |
| Wang, F | 1 |
| Zhang, Y | 1 |
| Kang, Y | 1 |
| Wang, H | 1 |
| Si, M | 1 |
| Su, L | 1 |
| Xin, X | 1 |
| Xue, F | 1 |
| Hao, F | 1 |
| Yu, L | 1 |
| Xu, J | 1 |
| Xue, M | 1 |
| Fan, X | 1 |
| Takahashi-Yanaga, F | 1 |
| Morimoto, S | 1 |
| Zhan, DY | 1 |
| Igawa, K | 1 |
| Tomooka, K | 1 |
| Sasaguri, T | 1 |
| Timmers, L | 1 |
| Sluijter, JP | 1 |
| Verlaan, CW | 1 |
| Steendijk, P | 1 |
| Cramer, MJ | 1 |
| Emons, M | 1 |
| Strijder, C | 1 |
| Gründeman, PF | 1 |
| Sze, SK | 1 |
| Hua, L | 1 |
| Piek, JJ | 1 |
| Borst, C | 1 |
| Pasterkamp, G | 1 |
| de Kleijn, DP | 1 |
| Jugdutt, BI | 1 |
5 other studies available for celecoxib and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
A hybrid platform featuring nanomagnetic ligand fishing for discovering COX-2 selective inhibitors from aerial part of Saussurea laniceps Hand.-Mazz.
Topics: Animals; Arthritis, Experimental; Celecoxib; Cell Line; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitor | 2021 |
Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress.
Topics: Animals; Apoptosis; Cardiomegaly; Cardiotonic Agents; Celecoxib; Cell Survival; Cyclooxygenase 2 Inh | 2016 |
Celecoxib and 2,5-dimethyl-celecoxib prevent cardiac remodeling inhibiting Akt-mediated signal transduction in an inherited dilated cardiomyopathy mouse model.
Topics: Animals; Cardiomyopathy, Dilated; Celecoxib; Disease Models, Animal; Dose-Response Relationship, Dru | 2011 |
Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig.
Topics: Animals; Blood Pressure; Cardiovascular Diseases; Celecoxib; Collagen; Cyclooxygenase 2; Cyclooxygen | 2007 |
Cyclooxygenase inhibition and adverse remodeling during healing after myocardial infarction.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cardiovascular Diseases; Celecoxib | 2007 |